Literature DB >> 15223956

Carcinoma of the ampulla of Vater: comparative histologic/immunohistochemical classification and follow-up.

Hui Zhou1, Nico Schaefer, Martin Wolff, Hans-Peter Fischer.   

Abstract

A broad histomorphologic spectrum of ampullary carcinomas of Vater make a reproducible histologic classification difficult. Using cytokeratin immunohistochemistry, we present a new classification of ampullary carcinomas and analyze their clinical significance. Fifty-five invasive carcinomas of Vater's ampulla were histologically classified into pancreaticobiliary, intestinal, and other types. Serial sections of all carcinoma specimens were additionally stained with antibodies to cytokeratins (CK7, CK20), apomucins (MUC1, MUC2, MUC5AC), CEA, CA19-9, Ki67, and p53. Follow-up of patients from 4 months to 22 years after surgery (mean interval, 51.6 months) was evaluated. Most carcinomas of the ampulla of Vater were of immunohistochemically pancreaticobiliary type (iPT, CK7+, CK20-; 54.5%) or intestinal type (immunohistochemically intestinal type [iIT], CK7-, CK20+; 23.6%). Some carcinomas of immunohistochemically "other" type (iOT both CK7+ and CK20+ or CK7- and CK20-; 21.8%) had precursor lesions of iIT or iPT. Carcinomas positive for MUC2 or CEA were associated with iIT (MUC2, P < 0.001; CEA, P = 0.003), whereas MUC5AC-positive carcinomas were related to iPT (P = 0.005). Our classification based on cytokeratin-immunohistochemistry correlated well with the histologic classification according to published criteria (kappa-coefficient = 0.398; P < 0.001). Furthermore, histologically unusual types could be histogenetically related to pancreaticobiliary duct mucosa or intestinal mucosa. Therefore, all 4 signet-ring cell carcinomas were iIT carcinomas. Thus, cytokeratin immunohistochemistry allows a reproducible, histogenetically based categorization of ampullary carcinomas. However, neither histopathologic nor immunohistochemical subgroups significantly correlated with clinical outcome in our German collective. The overall survival was significantly shorter in males (P = 0.032) and patients with positive nodal stage (N1 < N0; P = 0.0025).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15223956     DOI: 10.1097/00000478-200407000-00005

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  52 in total

1.  Immunohistochemical Predictors for Intestinal and Pancreatobiliary Types of Adenocarcinoma of The Ampulla of Vater.

Authors:  João Paulo Lemos da Silveira Santos; Carla Jorge Machado; Eduardo Paulino Junior; João Bernardo Sancio Rocha Rodrigues; Paula Teixeira Vidigal; Vivian Resende
Journal:  J Gastrointest Surg       Date:  2018-05-07       Impact factor: 3.452

2.  Impact of lymph node metastasis on survival in patients with pathological T1 carcinoma of the ampulla of Vater.

Authors:  Hiroshi Terasawa; Kazuhisa Uchiyama; Masaji Tani; Manabu Kawai; Takeshi Tsuji; Katsuyoshi Tabuse; Yasuhito Kobayashi; Katsutoshi Taniguchi; Hiroki Yamaue
Journal:  J Gastrointest Surg       Date:  2006-06       Impact factor: 3.452

Review 3.  An approach to duodenal biopsies.

Authors:  S Serra; P A Jani
Journal:  J Clin Pathol       Date:  2006-05-05       Impact factor: 3.411

4.  Tumor budding as a strong prognostic indicator in invasive ampullary adenocarcinomas.

Authors:  Nobuyuki Ohike; Ipek Coban; Grace E Kim; Olca Basturk; Takuma Tajiri; Alyssa Krasinskas; Sudeshna Bandyopadhyay; Toshio Morohoshi; Yuki Shimada; David A Kooby; Charles A Staley; Michael Goodman; N Volkan Adsay; Nazmi Volkan Adsay
Journal:  Am J Surg Pathol       Date:  2010-10       Impact factor: 6.394

5.  Prognostic factors for ampullary adenocarcinomas: tumor stage, tumor histology, tumor location, immunohistochemistry and microsatellite instability.

Authors:  Fausto Sessa; Daniela Furlan; Clementina Zampatti; Ileana Carnevali; Francesca Franzi; Carlo Capella
Journal:  Virchows Arch       Date:  2007-07-26       Impact factor: 4.064

Review 6.  Management of ampullary neoplasms: A tailored approach between endoscopy and surgery.

Authors:  Francesca Panzeri; Stefano Crippa; Paola Castelli; Francesca Aleotti; Alessandro Pucci; Stefano Partelli; Giuseppe Zamboni; Massimo Falconi
Journal:  World J Gastroenterol       Date:  2015-07-14       Impact factor: 5.742

7.  Sequencing of 279 cancer genes in ampullary carcinoma reveals trends relating to histologic subtypes and frequent amplification and overexpression of ERBB2 (HER2).

Authors:  Jaclyn F Hechtman; Weiguo Liu; Justyna Sadowska; Lisa Zhen; Laetitia Borsu; Maria E Arcila; Helen H Won; Ronak H Shah; Michael F Berger; Efsevia Vakiani; Jinru Shia; David S Klimstra
Journal:  Mod Pathol       Date:  2015-05-15       Impact factor: 7.842

8.  Clinical, morphologic, and immunophenotypic characteristics of ampullary carcinomas with an emphasis on SMAD4 expression.

Authors:  Ahmad Alkhasawneh; Lizette Vila Duckworth; Thomas J George; Neelam V Desai; Alex J Sommerfeld; Xiaomin Lu; Tania Zuluaga Toro
Journal:  J Gastrointest Oncol       Date:  2016-12

9.  Mucin 2 (MUC2) and mucin 5 (MUC5) expression is not associated with prognosis in patients with radically resected ampullary carcinoma.

Authors:  D Santini; A Baldi; B Vincenzi; P Mellone; M Campioni; A Antinori; D Borzomati; R Coppola; P Magistrelli; G Tonini
Journal:  J Clin Pathol       Date:  2007-09       Impact factor: 3.411

10.  Differentiation markers in pancreatic head adenocarcinomas: MUC1 and MUC4 expression indicates poor prognosis in pancreatobiliary differentiated tumours.

Authors:  Arne Westgaard; Aasa R Schjølberg; Milada Cvancarova; Tor J Eide; Ole Petter F Clausen; Ivar P Gladhaug
Journal:  Histopathology       Date:  2009-02       Impact factor: 5.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.